COPE offers ketamine infusion therapy and intranasal esketamine (Spravato) for patients with treatment-resistant mental illnesses. COPE is proud to provide administrative and advisory support to highly specialized psychiatric clinics in multiple locations around the country that provide expert consultations and innovative, evidence-based psychiatric treatment for the most difficult to treat cases of major depression, anxiety, bipolar depression, chronic pain and opioid addiction among others.